Thanks, similar circumstances with me. Some how I missed information on new facility. Invested with several thousand shares in early 2015. I want more. You have made it easier for me to make this decision. Agree with your assessment. Since no dilution for new manufacturing plant, things look promising. Appreciate your quick response.
Looking for more information about Canadian funding for the versafilm manufacturing facility you mentioned. Do you have more details about this? Is this confirmed, & do you know when facility will be completed? I am a new, small investor here in IGXT. Hoping to invest more soon if Canadian funding is definite.
Thanks, LadyD for your comment. Would you add to your observation concerning pain? Wondering about needle free injections, are they pain free?
I can see that the new patent is a comment on our management. Have they found something of value for the company? Or will the new patent be a distraction for them & maybe a waste of $s. I thank Loko for telling us about it so we can decide for ourselves. Had he not shared this information, we may have never known about it. My wild & crazy guess was just that, nothing else. However, I think it is a logical & possible conclusion if depression is CNS related, & I think it is. Got the clarification I want. I do think the Testosterone asset is of great value. I read here for the diversity of ideas. I appreciate all of your input. I will stay with ATRS or go some where else with my investment depending on my own analysis. Thanks!
Seeking the same information here that you are, but I don't have the chemistry or pharmaceutical background that is perhaps necessary to fully understand the issue. I have to believe that there is a very good reason for this patent. I don't believe they would have wasted the time or resources to pay to have somebody do the research on this & then, file for a world-wide patent otherwise. The only answer I have been able to come up with in this delivery approach (using ethanol, the utility of the method, & perhaps less bad side effects) is that management believes it will in some way limit or restrict any possible competition for some of their future products such as their testosterone SC shot. I believe LD has suggested this in his comments at Seeking Alpha. I like the fact that LD is a good researcher/detective & is willing to go out on a limb & make predictions. Since none of us seem to be insiders here, this is what we all have to do at times if we keep investing in these type businesses, & sometimes we could be wrong. I don't post much, but I read here everyday, & I am invested in ATRS. I still see some hope here.
He refers to himself as lokodude or something like that there, I believe. It is also a very interesting turn of events!
Lokodaug has provided additional clarification on this new patent at the end of Ali Yasar's last report on ATRS Testosterone injection plus the patent reference. What I saw looks significant to me, but I am not really qualified to evaluate the patent. Hope some of you will check this out & report back here your ideas.
I thought INO/ONCS agreements precluded this. I believe ONCS has exclusive right to inject/electroporate into tumors. When I held ONCS shares, I read or heard this in a presentation done by ONCS. No longer have ONCS shares. I now hold only INO because I think it is the better investment long term.
I guess sneezing & coughing would have to be out of the question for any user. Couldn't use in cold, flu, or allergy season.